Internal Medicine and Psoriasis

Psoriasis is incurable, it responds well to many topical and systemic treatments. Cyclosporine may be used for severe, difficult-to-treat cases of widespread psoriasis. Improvement and results may be very rapid in onset. Major possible side effects include kidney and blood-pressure problems. Methotrexate is a common drug used for rheumatoid arthritis, and it has been used effectively for many years in psoriasis. The drug may cause liver and lung damage. Close physician monitoring and monthly to quarterly visits and labs are generally required.

  • Psoriasis and Cancer
  • Metabolic syndrome and psoriasis
  • Psoriasis and cardiovascular disease
  • Microbiome and Psoriasis

Related Conference of Internal Medicine and Psoriasis

August 25-26, 2026

26th European Dermatology Congress

Paris, France
September 23-24, 2026

9th International Dermatology Conference: Skin and Body

Barcelona, Spain
October 27-28, 2026

20th International Conference on Alzheimers Disease & Dementia

Amsterdam, Netherlands
December 03-04, 2026

9th World Cosmetic and Dermatology Congress

Madrid, Spain
December 03-04, 2026

28th World Dermatology and Aesthetic Congress

Madrid, Spain
March 29-30, 2027

28th World Dermatology Congress

Paris, France

Internal Medicine and Psoriasis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in